DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients – Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group

✍ Scribed by Sabine Maier; Inko Nimmrich; Thomas Koenig; Serenella Eppenberger-Castori; Inga Bohlmann; Angelo Paradiso; Frédérique Spyratos; Christoph Thomssen; Volkmar Mueller; Jörg Nährig; Francesco Schittulli; Ronald Kates; Ralf Lesche; Ina Schwope; Antje Kluth; Almuth Marx; John W.M. Martens; John A. Foekens; Manfred Schmitt; Nadia Harbeck

• Book ID: 116429345
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 621 KB
• Volume: 43
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2007.04.025